UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years.
Extracorporeal membrane oxygenation (ECMO) is a supportive intensive-care technique used for babies with acute respiratory failure. We examined morbidity at age 4 years in surviving children recruited to the UK Collaborative ECMO Trial, and provide long-term data on ECMO support compared with contemporary conventional care. The neonatal ECMO policy resulted in improved survival and a favourable outcome. We therefore advocate the safety and efficacy of this intervention.
Bennett
C C
CC
Johnson
A
A
Field
D J
DJ
Elbourne
D
D
D000208:Acute Disease; D002675:Child, Preschool; D003071:Cognition; D015199:Extracorporeal Membrane Oxygenation; D005500:Follow-Up Studies; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D009422:Nervous System Diseases / Q000209:etiology; D012131:Respiratory Insufficiency / Q000150:complications / Q000401:mortality / Q000628:therapy*; D012307:Risk Factors; D016896:Treatment Outcome